Author

A. Murgaski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

D. Laoui· 2 shared H. Van Damme· 2 shared J. Keirsse· 2 shared M. Kiss· 2 shared Y. Elkrim· 2 shared A. D. Garg· 1 shared A. Debraekeleer· 1 shared A. E. I. Hamouda· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Laoui

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Distinct cDC subsets co-operate in CD40 agonist response while suppressive microenvironments and lack of antigens subvert efficacy

A. Murgaski, M. Kiss, H. Van Damme, D. Kancheva, I. Vanmeerbeek, J. Keirsse, E. Hadadi, J. Brughmans, S. M. Arnouk, A. E. I. Hamouda, A. Debraekeleer, V. Bosteels, Y. Elkrim, L. Boon, S. Hoves, , D. Laoui

This study identifies cDC subsets that cooperate in CD40 agonist response and shows that suppressive microenvironments and antigen scarcity limit its efficacy in cancer.

bioRxiv · Dec 25, 2021 · PreprintCancer Biology

Inflammasome- and gasdermin D-independent IL-1β production mobilizes neutrophils to inhibit antitumor immunity

M. Kiss, L. Vande Walle, E. Lebegge, H. Van Damme, A. Murgaski, J. Qian, M. Ehling, S. Pretto, E. Bolli, J. Keirsse, Y. Elkrim, M. S. Martins, A. Fossoul, D. Lambrechts, M. Mazzone, , D. Laoui

This study shows IL-1β promotes tumor progression by mobilizing neutrophils to suppress antitumor immunity, independent of inflammasome and GSDMD.

bioRxiv · Aug 4, 2020Immunology